187 related articles for article (PubMed ID: 35816064)
1. An Up-to-Date Approach to the Management of Dissecting Cellulitis.
Nussbaum D; Desai S; Nelson K; Saardi K; Friedman A
J Drugs Dermatol; 2022 Jul; 21(7):800-802. PubMed ID: 35816064
[TBL] [Abstract][Full Text] [Related]
2. Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors: A case report and review of published cases.
Takahashi T; Yamasaki K; Terui H; Omori R; Tsuchiyama K; Fujimura T; Aiba S
J Dermatol; 2019 Sep; 46(9):802-807. PubMed ID: 31271451
[TBL] [Abstract][Full Text] [Related]
3. Refractory Dissecting Cellulitis of the Scalp Treated With Risankizumab.
Babalola F; Chima M; Jobarteh R; Gottlieb A
J Drugs Dermatol; 2022 Mar; 21(3):313-314. PubMed ID: 35254754
[TBL] [Abstract][Full Text] [Related]
4. Are dissecting cellulitis and hidradenitis suppurativa different diseases?
Federico A; Rossi A; Caro G; Magri F; Muscianese M; Di Fraia M; Carlesimo M
Clin Dermatol; 2021; 39(3):496-499. PubMed ID: 34518010
[TBL] [Abstract][Full Text] [Related]
5. Dissecting cellulitis (Perifolliculitis Capitis Abscedens et Suffodiens): a comprehensive review focusing on new treatments and findings of the last decade with commentary comparing the therapies and causes of dissecting cellulitis to hidradenitis suppurativa.
Scheinfeld N
Dermatol Online J; 2014 May; 20(5):22692. PubMed ID: 24852785
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic options for perifolliculitis capitis abscedens et suffodens: A review.
Wu Q; Bu W; Zhang Q; Fang F
Dermatol Ther; 2022 Oct; 35(10):e15763. PubMed ID: 35946169
[TBL] [Abstract][Full Text] [Related]
7. The importance of histopathologic aspects in the diagnosis of dissecting cellulitis of the scalp.
Brănişteanu DE; Molodoi A; Ciobanu D; Bădescu A; Stoica LE; Brănişteanu D; Tolea I
Rom J Morphol Embryol; 2009; 50(4):719-24. PubMed ID: 19942972
[TBL] [Abstract][Full Text] [Related]
8. Atypical pediatric presentation of alopecic and aseptic nodules of the scalp with features of dissecting cellulitis.
Gambichler T; Scheel CH; Chatzipantazi M; Kautz O; Heinzer E; Boms S
Pediatr Dermatol; 2023; 40(6):1155-1156. PubMed ID: 37253654
[TBL] [Abstract][Full Text] [Related]
9. Perifolliculitis capitis abscedens et suffodiens successfully controlled with topical isotretinoin.
Karpouzis A; Giatromanolaki A; Sivridis E; Kouskoukis C
Eur J Dermatol; 2003; 13(2):192-5. PubMed ID: 12695138
[TBL] [Abstract][Full Text] [Related]
10. A case of dissecting cellulitis and a review of the literature.
Scheinfeld NS
Dermatol Online J; 2003 Feb; 9(1):8. PubMed ID: 12639466
[TBL] [Abstract][Full Text] [Related]
11. Hidradenitis suppurativa with perifolliculitis capitis abscedens et suffodiens successfully treated with a human anti-tumour necrosis factor monoclonal antibody.
Minakawa S; Matsuzaki Y; Rokunohe D; Kumagai N; Kurose A; Kushibiki M; Kayaba H; Sawamura D
Clin Exp Dermatol; 2021 Dec; 46(8):1586-1588. PubMed ID: 34096639
[No Abstract] [Full Text] [Related]
12. Follicular occlusion tetrad in a male patient with pachyonychia congenita: clinical and genetic analysis.
Musumeci ML; Fiorentini F; Bianchi L; Cascella R; Giardina E; Caputo V; Micali G
J Eur Acad Dermatol Venereol; 2019 Oct; 33 Suppl 6():36-39. PubMed ID: 31535756
[TBL] [Abstract][Full Text] [Related]
13. Perifolliculitis Capitis Abscedens et Suffodiens Treated with Anti-tumor Necrosis Factor-alpha - Possible New Treatment Option.
Sjerobabski Masnec I; Franceschi N
Acta Dermatovenerol Croat; 2018 Oct; 26(3):255-289. PubMed ID: 30390728
[TBL] [Abstract][Full Text] [Related]
14. Dissecting cellulitis of the scalp treated with rifampicin and isotretinoin: case reports.
Georgala S; Korfitis C; Ioannidou D; Alestas T; Kylafis G; Georgala C
Cutis; 2008 Sep; 82(3):195-8. PubMed ID: 18856159
[TBL] [Abstract][Full Text] [Related]
15. Perifolliculitis capitis abscedens et suffodiens in a caucasian: diagnostic and therapeutic challenge.
Mihić LL; Tomas D; Situm M; Krolo I; Sebetić K; Sjerobabski-Masnec I; Barišić F
Acta Dermatovenerol Croat; 2011; 19(2):98-102. PubMed ID: 21703156
[TBL] [Abstract][Full Text] [Related]
16. Determinant factors of biological therapy for dissecting cellulitis of the scalp.
Melgosa Ramos FJ; Berna-Rico E; Suarez-Valle A; Mateu Puchades A; Vañó-Galván S; García-Ruiz R; Saceda Corralo D
J Dtsch Dermatol Ges; 2024 Jan; 22(1):115-117. PubMed ID: 38110849
[No Abstract] [Full Text] [Related]
17. Photodynamic therapy combined with dermatosurgical approach for Perifolliculitis Capitis Abscedens et Suffodiens.
Cui X; Zhu J; Yao X; Zhu W; Xu P; Wu X
Photodiagnosis Photodyn Ther; 2020 Jun; 30():101767. PubMed ID: 32305655
[TBL] [Abstract][Full Text] [Related]
18. Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors and baricitinib: A case report and literature review.
Yu Y; Ding X; Guo F; Ze K; Sun X; Li X
Front Med (Lausanne); 2023; 10():1132574. PubMed ID: 37056728
[TBL] [Abstract][Full Text] [Related]
19. Perifolliculitis Capitis Abscedens et Suffodiens Treated with Systemic Isotretinoin Monotherapy: Case Report and Review of Current Therapeutic Options.
Rallis E; Verros C; Katoulis A
Acta Dermatovenerol Croat; 2022 Dec; 30(4):256-260. PubMed ID: 36919393
[TBL] [Abstract][Full Text] [Related]
20. Perifolliculitis capitis abscedens et suffodiens with hidradenitis suppurativa and nodulocystic acne treated with adalimumab.
Kurokawa I
J Dermatol; 2021 Aug; 48(8):e374-e375. PubMed ID: 33960498
[No Abstract] [Full Text] [Related]
[Next] [New Search]
